ARTICLE | Distillery Therapeutics


November 30, 2016 2:19 PM UTC

Patient sample, cell culture and mouse studies suggest promoting MAPK12 expression could help treat AD. In postmortem cortex tissue samples from AD patients, low levels of MAPK12 correlated with disea...

BCIQ Company Profiles

University of New South Wales

BCIQ Target Profiles

MAP kinase 12 (MAPK12) (ERK-3)